isospaglumic acid has been researched along with pepstatin in 1 studies
| Studies (isospaglumic acid) | Trials (isospaglumic acid) | Recent Studies (post-2010) (isospaglumic acid) | Studies (pepstatin) | Trials (pepstatin) | Recent Studies (post-2010) (pepstatin) |
|---|---|---|---|---|---|
| 469 | 31 | 116 | 696 | 0 | 125 |
| Protein | Taxonomy | isospaglumic acid (IC50) | pepstatin (IC50) |
|---|---|---|---|
| Pepsin A | Sus scrofa (pig) | 0.011 | |
| Renin | Homo sapiens (human) | 1.9333 | |
| Cathepsin D | Homo sapiens (human) | 0.3597 | |
| Procathepsin L | Homo sapiens (human) | 0.8 | |
| Cathepsin B | Homo sapiens (human) | 4.26 | |
| Candidapepsin-2 | Candida albicans | 0.09 | |
| Pepsin A-5 | Homo sapiens (human) | 0.059 | |
| Cathepsin E | Homo sapiens (human) | 0.5558 | |
| Plasmepsin-1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0009 | |
| Plasmepsin-2 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0005 | |
| Cathepsin D | Bos taurus (cattle) | 0.0235 | |
| Disintegrin and metalloproteinase domain-containing protein 9 | Homo sapiens (human) | 0.0563 | |
| Plasmepsin 4 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0003 | |
| Cysteine protease | Leishmania donovani | 0.16 | |
| Protease | Human immunodeficiency virus 1 | 0.947 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barczak, AK; Coyle, JT; Luthi-Carter, R; Speno, H | 1 |
1 other study(ies) available for isospaglumic acid and pepstatin
| Article | Year |
|---|---|
Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.
Topics: Animals; Antigens, Surface; Binding, Competitive; Carboxypeptidases; Chelating Agents; Cloning, Molecular; Cobalt; Coumarins; Dipeptides; Edetic Acid; Folic Acid; Glutamate Carboxypeptidase II; Histamine H1 Antagonists; Humans; Hydrolysis; Isocoumarins; Kinetics; Leucine; Male; Neuropeptides; Pepstatins; Phenanthrolines; Prostatic Neoplasms; Protease Inhibitors; Rats; Serine Proteinase Inhibitors; Substrate Specificity; Synaptic Transmission; Tumor Cells, Cultured | 1998 |